Avanos Medical (AVNS) Return on Invested Capital (2014 - 2026)

Avanos Medical (AVNS) has 8 years of Return on Invested Capital data on file, last reported at 0.02% in Q1 2026.

• For the quarter ending Q1 2026, Return on Invested Capital rose 8.0% year-over-year to 0.02%; the trailing twelve-month figure through Mar 2026 stood at 0.02% (up 8.0% YoY), and the FY2025 full-year result was 0.07%, up 35.0% from the prior year.
• Return on Invested Capital rose to 0.02% in Q1 2026, from 0.02% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.03% in Q4 2022 to a low of 0.12% in Q3 2025.
• A 5-year average of 0.03% and a median of 0.0% in 2024 frame the typical range for Return on Invested Capital.
• Peak annual rise in Return on Invested Capital reached 8 bps in 2025, while the deepest fall reached 13 bps in 2025.
• Tracing AVNS's Return on Invested Capital over 5 years: stood at 0.03% in 2022, then sank by 93 bps to 0.0% in 2023, then sank by 5033 bps to 0.1% in 2024, then jumped by 82 bps to 0.02% in 2025, then advanced by 2 bps to 0.02% in 2026.
• Business Quant data shows AVNS's Return on Invested Capital at 0.02% in Q1 2026, 0.02% in Q4 2025, and 0.12% in Q3 2025.